{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260805760759/en/U.S.-FDA-Approves-Takeda%E2%80%99s-ORZEYFUL%E2%84%A2-oveporexton-the-First-and-Only-Medicine-to-Treat-the-Underlying-Cause-of-Narcolepsy-Type-1", "message": "News view counter 867536 successfully enlarged"}